Invasive fungal infection in very low birthweight infants: National prospective surveillance study

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 91, Issue 3, 2006, Pages

  Clerihew, L ^b   Lamagni, T L ^c   Brocklehurst, P ^d   McGuire, W ^a,e  

^a CANBERRA HOSPITAL   (Australia)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE;

ARTICLE; BONE MARROW TOXICITY; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FUNGUS ISOLATION; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INFANT MORTALITY; MYCOSIS; NEPHROTOXICITY; NEWBORN INFECTION; POPULATION RESEARCH; PRIORITY JOURNAL; UNITED KINGDOM; VERY LOW BIRTH WEIGHT;

ANTIFUNGAL AGENTS; EARLY DIAGNOSIS; GESTATIONAL AGE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MYCOSES; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33646374448     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2005.082024     Document Type: Article

References (24)

1. Benjamin DK Jr, Poole C, Steibach WJ, et al. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112:634-40.
2. Kossoft EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998;17:504-8.
3. Stall BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Peadiatrics 2002;110:285-91.
4. Makhoul IR, Sujov P, Smolkin T, et al. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109:34-9.
5. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 2000;19:319-24.
6. Benjamin DK Jr, Ross K, McKinney RE Jr, et al. hen to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 2000;106:712-18.
7. Lopez Sastre JB, Goto Cotallo GD, Fernandez Colomer B. Grupo de Hospitales Castrillo. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 2003;20:153-63.
8. Johnsson H, Ewald U. The rate of candidaemia in preterm infants born at a gestational age of 23-28 weeks is inversely correlated to gestational age. Acta Paediatr 2004;93:954-8.
9. Schelonka RL, Moser SA. Time to positive culture results in neonatal Candida septicemia. J Pediatr 2003;142:564-5.
10. Koufman D. Strategies for prevention of neonatal invasive candidiasis. Semin Perinatol 2003;27:414-24.
11. Austin NC, Darlow B. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants. Cochrane Database Syst Rev 2004;2.
12. McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 2003;1.
13. Sims ME, Yoo Y, You H, et al. Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. Am J Perinatol 1988;5:33-6.
14. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660-6.
15. Melville C, Kempley S, Graham J, et al. Early onset systemic Candida infection in extremely preterm neonates. Eur J Pediatr 1996;155:904-6.
16. Stall BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347:240-7.
17. Rowen JL, Tate JM. Management of neonatal candidiasis. Neonatal Candidiasis Study Group. Pediatr Infect Dis J 1998;17:1007-11.
18. Clerihew L, McGuire W. Systemic antifungal drugs for invasive fungal infection in preterm infants. Cochrane Database Syst Rev 2004;1.
19. Johansen HK, Gotzsche PC. Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia. Cochrane Database Syst Rev 2002:4.
20. Johansen HK, Gotzsche PC. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. Cochrane Database Syst Rev 2002;4.
21. Adler-Shohet F, Waskin H, Lieberman JM. Amphotericin B lipid complex for neonatal invasive candidiasis. Arch Dis Child Fetal Neonatal Ed 2001;84:F131-3.
22. Huttova M, Hartmanova I, Kralinsky K, et al. Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. Pediatr Infect Dis J 1998;17:1012-15.
23. Benjamin DK Jr, De Long ER, Steibach WJ, et al. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 2003;112:543-7.
24. Gørtzsche PC, Johansen MK. Routine versus selective antifungal administration for control of fungal infections in patients with cancer. Cochrane Database Syst Rev 2002;2.